NovelStem International (NSTM) Stock Overview
A development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
NSTM Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
NovelStem International Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.018 |
| 52 Week High | US$0.039 |
| 52 Week Low | US$0.0081 |
| Beta | 2.24 |
| 1 Month Change | 2.22% |
| 3 Month Change | 2.22% |
| 1 Year Change | 41.54% |
| 3 Year Change | -89.78% |
| 5 Year Change | -90.80% |
| Change since IPO | -99.78% |
Recent News & Updates
Recent updates
Shareholder Returns
| NSTM | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 31.4% | 3.6% | -0.4% |
| 1Y | 41.5% | 26.9% | 12.7% |
Return vs Industry: NSTM exceeded the US Biotechs industry which returned 26.9% over the past year.
Return vs Market: NSTM exceeded the US Market which returned 12.7% over the past year.
Price Volatility
| NSTM volatility | |
|---|---|
| NSTM Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 11.0% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: NSTM's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine NSTM's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | n/a | n/a | www.novelstem.com |
NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is headquartered in Boca Raton, Florida.
NovelStem International Corp. Fundamentals Summary
| NSTM fundamental statistics | |
|---|---|
| Market cap | US$862.62k |
| Earnings (TTM) | US$2.31m |
| Revenue (TTM) | US$3.00k |
Is NSTM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NSTM income statement (TTM) | |
|---|---|
| Revenue | US$3.00k |
| Cost of Revenue | US$0 |
| Gross Profit | US$3.00k |
| Other Expenses | -US$2.30m |
| Earnings | US$2.31m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.049 |
| Gross Margin | 100.00% |
| Net Profit Margin | 76,872.07% |
| Debt/Equity Ratio | -89.2% |
How did NSTM perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/26 18:57 |
| End of Day Share Price | 2026/01/21 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
NovelStem International Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.